RFK Jr. Says FDA Will Lift Ban on Peptides

MedPage Today·Mar 6

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA is reportedly considering easing restrictions on certain peptides, with some outlets suggesting a ban may be lifted. However, the extent to which the FDA will relax its rules is unclear, with some reports indicating a meeting to discuss broader access and others citing concerns over safety. Former FDA officials have also disputed characterizations of the agency's work on the issue by RFK Jr.

Full coverage

FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters

PBS·Apr 15

FDA moves toward easing restrictions on certain peptides

BioPharma Dive·Apr 16

RFK Jr. may reverse a peptide ban he calls 'illegal.' Former FDA officials say he mischaracterized their work.

The Lund Report·Apr 14

Heeding Kennedy’s Wishes, F.D.A. Is Expected to Lift Restriction on Peptides

The New York Times·Mar 31

FDA panel will meet to discuss allowing broader access to certain peptides

STAT·Apr 15

RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work.

ProPublica·Apr 3

RFK Jr.’s Plan for Easier Access to Peptides Clashes With FDA Safety Concerns

inc.com·Mar 3

RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban

Ars Technica·Apr 16

View original report at MedPage Today ↗

Fetching the latest headlines…